Microfluidic Manufacturing Improves Polydispersity of Multicomponent Polymeric Nanoparticles


Authors: K. Abstiens and A.M. Goepferich

Journal: Journal of Drug Delivery Science and Technology

DOI: 10.1016/j.jddst.2018.12.009

Publication - Abstract

December 05, 2018

Abstract

A key challenge in manufacturing of multicomponent polymeric colloids is obtaining monodisperse nanoparticles (NPs) with reproducible characteristics. Herein, NP formulations with varying core to shell ratios were either prepared by bulk nanoprecipitation or microfluidic synthesis and evaluated regarding their size and polydispersity. Microfluidic process parameters, such as the total flow rate (TFR) and the flow rate ratio (FRR) of the aqueous phase and the organic polymer solution, were varied to tune particle size and further improve size distribution. In general, bulk nanoprecipitation resulted in formation of larger particles (52–65 nm) with a wide size distribution, whereas particles were significantly smaller in size (24–43 nm) and displayed a rather monodisperse size distribution when they were manufactured with a microfluidic system. The FRR was identified to be the key factor for improving the size distribution of NPs with a high ratio of PLA-PEG to PLGA, whereas it had only minor impact on particle characteristics of formulations with a lower copolymer ratio. Polydispersity of different NP formulations was successfully improved by microfluidic manufacturing, demonstrating that this technology is a valuable tool that allows for reproducible and scalable manufacturing of multicomponent NPs with precisely tunable quality attributes.

Advanced Search

close
  • Publications
  • Application Notes
  • Posters
  • Workshops
  • Videos & Webinars
  • Blog Posts
Search

Browse by Category

  • Application
    • Diagnostic and Imaging
    • Genetic Medicine
    • Hematology
    • Metabolic Disorders
    • Neuroscience
    • Oncology
    • Skeletal Disorders
    • Targeted Drug Delivery
    • Vaccines
    • Other Applications
    • Cell therapy
  • Formulation
    • Liposomes
    • Nucleic Acid Lipid Nanoparticles
    • Polymeric Nanoparticles
    • Other Formulations
  • Payload
    • DNA
    • microRNA
    • mRNA
    • siRNA
    • Small Molecule Drugs
    • Other Payloads


related content

Publication - Abstract

Investigating the Impact of Delivery System Design on the Efficacy of Self-Amplifying RNA Vaccines

G. Anderluzzi, G. Lou, S. Gallorini, M. Brazzoli, R. Johnson, D.T. O'Hagan, B.C. Baudner and Y. Perrie

messenger RNA (mRNA)-based vaccines combine the positive attributes of both live-attenuated and subunit vaccines. In order for these to be applied for clinical use, they require to be formulated with delivery systems. However, there are limited in vivo studies which...
Read More


Publication - Abstract

Optimizing Biodegradable Nanoparticle Size for Tissue-specific Delivery

H.K. Mandl, E. Quijano, H.W. Suh, E. Sparago, S. Oeck, M. Grun, P.M. Glazer, and W.M. Saltzman

Nanoparticles (NPs) are promising vehicles for drug delivery because of their potential to target specific tissues [1]. Although it is known that NP size plays a critical role in determining their biological activity, there are few quantitative studies of the role of NP size in d...
Read More


Sign Up and Stay Informed
Sign up today to automatically receive new Precision NanoSystems application notes, conference posters, relevant science publications, and webinar invites.